Literature DB >> 23959855

Specific recruitment of γδ regulatory T cells in human breast cancer.

Jian Ye1, Chunling Ma, Fang Wang, Eddy C Hsueh, Karoly Toth, Yi Huang, Wei Mo, Shuai Liu, Bing Han, Mark A Varvares, Daniel F Hoft, Guangyong Peng.   

Abstract

Understanding the role of different subtypes of tumor-infiltrating lymphocytes (TIL) in the immunosuppressive tumor microenvironment is essential for improving cancer treatment. Enriched γδ1 T-cell populations in TILs suppress T-cell responses and dendritic cell maturation in breast cancer, where their presence is correlated negatively with clinical outcomes. However, mechanism(s) that explain the increase in this class of regulatory T cells (γδ Treg) in patients with breast cancer have yet to be elucidated. In this study, we show that IP-10 secreted by breast cancer cells attracted γδ Tregs. Using neutralizing antibodies against chemokines secreted by breast cancer cells, we found that IP-10 was the only functional chemokine that causes γδ Tregs to migrate toward breast cancer cells. In a humanized NOD-scid IL-2Rγ(null) (NSG) mouse model, human breast cancer cells attracted γδ Tregs as revealed by a live cell imaging system. IP-10 neutralization in vivo inhibited migration and trafficking of γδ Tregs into breast tumor sites, enhancing tumor immunity mediated by tumor-specific T cells. Together, our studies show how γδ Tregs accumulate in breast tumors, providing a rationale for their immunologic targeting to relieve immunosuppression in the tumor microenvironment. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23959855      PMCID: PMC3800256          DOI: 10.1158/0008-5472.CAN-13-0348

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

1.  TLR agonists induce regulatory dendritic cells to recruit Th1 cells via preferential IP-10 secretion and inhibit Th1 proliferation.

Authors:  Cheng Qian; Huazhang An; Yizhi Yu; Shuxun Liu; Xuetao Cao
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

2.  CD8+ gammadelta T regulatory cells mediate kidney allograft prolongation after oral exposure to alloantigen.

Authors:  Juan Zhou; Sarah E Appleton; Andrew Stadnyk; Timothy D G Lee; Bjorn A P Nashan
Journal:  Transpl Int       Date:  2008-04-23       Impact factor: 3.782

Review 3.  Immunosuppressive strategies that are mediated by tumor cells.

Authors:  Gabriel A Rabinovich; Dmitry Gabrilovich; Eduardo M Sotomayor
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

4.  Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo.

Authors:  Daniel J Powell; Aloisio Felipe-Silva; Maria J Merino; Mojgan Ahmadzadeh; Tamika Allen; Catherine Levy; Donald E White; Sharon Mavroukakis; Robert J Kreitman; Steven A Rosenberg; Ira Pastan
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

5.  The expanding universe of regulatory T cell subsets in cancer.

Authors:  Thomas F Gajewski
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

6.  CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion.

Authors:  Brian Kavanagh; Shaun O'Brien; David Lee; Yafei Hou; Vivian Weinberg; Brian Rini; James P Allison; Eric J Small; Lawrence Fong
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

7.  Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration.

Authors:  Daniel J Powell; Peter Attia; Victor Ghetie; John Schindler; Ellen S Vitetta; Steven A Rosenberg
Journal:  J Immunother       Date:  2008 Feb-Mar       Impact factor: 4.456

8.  Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway.

Authors:  Guangyong Peng; Helen Y Wang; Weiyi Peng; Yukiko Kiniwa; Kook Heon Seo; Rong-Fu Wang
Journal:  Immunity       Date:  2007-07-26       Impact factor: 31.745

9.  Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.

Authors:  Michael A Morse; Amy C Hobeika; Takuya Osada; Delila Serra; Donna Niedzwiecki; H Kim Lyerly; Timothy M Clay
Journal:  Blood       Date:  2008-06-02       Impact factor: 22.113

10.  CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.

Authors:  Yukiko Kiniwa; Yoshihiro Miyahara; Helen Y Wang; Weiyi Peng; Guangyong Peng; Thomas M Wheeler; Timothy C Thompson; Lloyd J Old; Rong-Fu Wang
Journal:  Clin Cancer Res       Date:  2007-12-01       Impact factor: 12.531

View more
  49 in total

1.  Tumor-infiltrating CD39+γδTregs are novel immunosuppressive T cells in human colorectal cancer.

Authors:  Guoming Hu; Pin Wu; Pu Cheng; Zhigang Zhang; Zhen Wang; Xiuyan Yu; Xuan Shao; Dang Wu; Jun Ye; Tao Zhang; Xiaochen Wang; Fuming Qiu; Jun Yan; Jian Huang
Journal:  Oncoimmunology       Date:  2017-01-06       Impact factor: 8.110

2.  Murine lung cancer induces generalized T-cell exhaustion.

Authors:  Rohit Mittal; Ching-Wen Chen; John D Lyons; Lindsay M Margoles; Zhe Liang; Craig M Coopersmith; Mandy L Ford
Journal:  J Surg Res       Date:  2015-02-12       Impact factor: 2.192

3.  Human regulatory γδT cells and their functional plasticity in the tumor microenvironment.

Authors:  Hui Chen; Wei He
Journal:  Cell Mol Immunol       Date:  2017-08-28       Impact factor: 11.530

Review 4.  γδ T Cells: Unexpected Regulators of Cancer Development and Progression.

Authors:  Christopher Fleming; Samantha Morrissey; Yihua Cai; Jun Yan
Journal:  Trends Cancer       Date:  2017-07-17

Review 5.  The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?

Authors:  Domenico Galati; Serena Zanotta; Marialuisa Bocchino; Rosaria De Filippi; Antonio Pinto
Journal:  Cancer Immunol Immunother       Date:  2021-01-01       Impact factor: 6.968

6.  Sox2 Communicates with Tregs Through CCL1 to Promote the Stemness Property of Breast Cancer Cells.

Authors:  Yingxi Xu; Xiaoli Dong; Pingping Qi; Yujie Ye; Wenzhi Shen; Liang Leng; Lina Wang; Xuefei Li; Xiaohe Luo; Yanan Chen; Peiqing Sun; Rong Xiang; Na Li
Journal:  Stem Cells       Date:  2017-12       Impact factor: 6.277

7.  Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.

Authors:  Jaime A Espinoza; Shakila Jabeen; Richa Batra; Elena Papaleo; Vilde Haakensen; Vera Timmermans Wielenga; Maj-Lis Møller Talman; Nils Brunner; Anne-Lise Børresen-Dale; Pavel Gromov; Åslaug Helland; Vessela N Kristensen; Irina Gromova
Journal:  Oncoimmunology       Date:  2016-10-24       Impact factor: 8.110

Review 8.  Lymphocyte-mediated Immune Regulation in Health and Disease: The Treg and γδ T Cell Co-conspiracy.

Authors:  Kyle K Payne
Journal:  Immunol Invest       Date:  2016-09-12       Impact factor: 3.657

Review 9.  Hunting for clinical translation with innate-like immune cells and their receptors.

Authors:  W Scheper; C Gründer; T Straetemans; Z Sebestyen; J Kuball
Journal:  Leukemia       Date:  2013-12-18       Impact factor: 11.528

Review 10.  γδ T cells in cancer.

Authors:  Bruno Silva-Santos; Karine Serre; Håkan Norell
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.